NM_005195.4:c.542G>C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM2BP4_StrongBS2
The NM_005195.4(CEBPD):c.542G>C(p.Ser181Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000363 in 1,378,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005195.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000755 AC: 1AN: 132400Hom.: 0 AF XY: 0.0000134 AC XY: 1AN XY: 74390
GnomAD4 exome AF: 0.00000363 AC: 5AN: 1378874Hom.: 0 Cov.: 31 AF XY: 0.00000293 AC XY: 2AN XY: 681730
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.542G>C (p.S181T) alteration is located in exon 1 (coding exon 1) of the CEBPD gene. This alteration results from a G to C substitution at nucleotide position 542, causing the serine (S) at amino acid position 181 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at